Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Docetaxel still the optimal first choice for symptomatic metastatic castration-resistant prostate cancer.

Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Docetaxel still the optimal first choice for symptomatic metastatic castration-resistant prostate cancer. Clin Adv Hematol Oncol. 2015 May;13(5):293-5 Authors: Dreicer R PMID: 26352772 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26352772?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - November 18, 2015 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research